Popular Articles

10 Million H1N1 Vaccines Ordered By Australia
Reports are coming in that the government of Australia has placed an order for 10 million vaccines against the novel H1N1 swine flu virus, following a press briefing from Health Minister Nicola
drugs without prescription
WHO Urges H1N1 Vaccine Producers To Give 10 Per Cent To Poor Countries
The World Health Organization (WHO) urged pharmaceutical companies to donate at least 10 per cent of their H1N1 pandemic swine flu vaccine
News of the day
National Wildlife Federation: Time Outdoors Improves Nation's Health
The Centers for Disease Control and Prevention (CDC) this week held an inaugural conference on obesity prevention and control. The CDC"s Division of Nutrition, Physical Activity, and Obesity convened in Washington, D.C. to chart ways to improve access to healthy places, discuss opportunities for obesity prevention, and plan physical education standards in schools through federal policy.
Health Insurance

Liver Failure: Is Molecular Adsorbent Recirculating System Effective?

Since its introduction in 1993, molecular adsorbent recirculating system (MARS) albumin dialysis has been a subject of research, with the hope of effectively treating patients with acute liver failure. The impact of MARS treatment on outcome as well as clinical and laboratory variables has been investigated widely in small non-randomized studies. However, larger studies with longer follow-up time are required to determine the true usefulness of MARS treatment in different liver failure etiologies. The research led by Taru Kantola from Helsinki University Central Hospital, Finland discussed the prognostic factors for survival in patients with acute liver failure. The authors analysed the 1-year outcomes of 188 patients treated with MARS from 2001 to 2007, in an intensive care unit specializing in liver diseases. They found that the etiology of liver failure was the most important predictor of survival. In acute liver failure (ALF) of toxic etiology (e.g., paracetamol), the grade of encephalopathy before MARS treatment was a significant prognostic factor. In ALF of unknown etiology, coagulation factor 5 and liver enzyme alanine aminotransferase levels were prognostic. According to the results, the MARS treatment of a cirrhotic patient with an acute-on-chronic liver failure is not meaningful in terms of prognosis if the patient is not eligible for transplantation. Reference: Kantola T, Koivusalo AM, Parmanen S, Hç¶ckerstedt K, Isoniemi H. Survival predictors in patients treated with a molecular adsorbent recirculating system. World J Gastroenterol 2009; 15(24): 3015-3024. Lai-Fu Li World Journal of Gastroenterology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):